1例重症肌无力患者合并病毒感染相关性暴发性心肌炎及文献复习
摘要
关键词
全文:
PDF参考
[1]Kociol,Robb D et al.“Recognition and Initial Management of Fulminant Myocarditis:A Scientific Statement From the American Heart Association.”Circulation vol.141,6 (2020):e69-e92.doi:10.1161/CIR.0 000000000000745.
[2]Tschöpe,Carsten et al.“Myocarditis and inflammatory cardiomyopathy:current evidence and future directions.”Nature reviews.Cardiology vol. 18,3(2021):169-193.doi:10.1038/s41569-020-00435-x.
[3]Hamming,I et al.“Tissue distribution of ACE2 protein,the functional receptor for SARS coronavirus.A first step in understanding SARS pathogenesis.”The Journal of pathology vol.203,2 (2004):631-7.doi:10.1002/path.1570.
[4]Gilhus,Nils Erik,and Jan J Verschuuren. “Myasthenia gravis:subgroup classification and therapeutic strategies.”The Lancet.Neurology vol. 14,10(2015):1023-36.doi:10.1016/S1474-4422(15)0014 5-3.
[5]Liu,P P,and J W Mason.“Advances in the understanding of myocarditis.”Circulation vol. 104,9(2001):1076-82.doi:10.1161/hc3401.095198.
[6]Kawai,C.“From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future.”Circulation vol.99,8 (1999):1091-100.doi:10.1161/01.cir.99.8.1091.
[7]Dalakas,Marinos C.“Immunotherapy in myasthenia gravis in the era of biologics.”Nature reviews.Neurology vol.15,2(2019):113-124.doi:10.10 38/s41582-018-0110-z.
(12 摘要 Views, 19 PDF Downloads)
Refbacks
- 当前没有refback。